Achieve life sciences, inc.ACHV.US Overview

US StockHealthcare

(No presentation for ACHV)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

ACHV Overall Performance

ACHV AI Analysis & Strategy

ACHV Recent Performance

-3.14%

Achieve life sciences, inc.

0.81%

Avg of Sector

-1.14%

S&P500

ACHV PowerScanner

ACHV Key Information

ACHV Valuation Metrics

ACHV Earnings Table

ACHV Profile

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.